[Ranibizumab as a treatment for type 2 non-proliferative macular telangiectasia].

[1]  D. Pelayes,et al.  Intravitreal Bevacizumab for Type 2 Idiopathic Macular Telangiectasia , 2013, Ophthalmic Research.

[2]  L. Yannuzzi,et al.  Idiopathic Macular Telangiectasia Type 2: The Progressive Vasculopathy , 2013, European journal of ophthalmology.

[3]  Y. Kim,et al.  Use of intravitreal bevacizumab injections to treat type 1 idiopathic macular telangiectasia , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  Ronald Klein,et al.  The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study. , 2010, American journal of ophthalmology.

[5]  R. Guymer,et al.  THE PREVALENCE ESTIMATES OF MACULAR TELANGIECTASIA TYPE 2: The Melbourne Collaborative Cohort Study , 2010, Retina.

[6]  E. Tsironi,et al.  Resolution of macular edema in idiopathic juxtafoveal telangiectasis using PDT. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.